Jagiasi Bharat G, Chhallani Akshaykumar A, Dixit Subhal B, Kumar Rishi, Pandit Rahul A, Govil Deepak, Prayag Shirish, Zirpe Kapil G, Mishra Rajesh C, Chanchalani Gunjan, Kapadia Farhad N
Critical Care Department, Reliance Hospital, Navi Mumbai, Maharashtra, India.
Akshjyot Clinic, Mumbai, Maharashtra, India.
Indian J Crit Care Med. 2022 Oct;26(Suppl 2):S51-S65. doi: 10.5005/jp-journals-10071-24195.
Deep vein thrombosis (DVT) is a preventable complication of critical illness, and this guideline aims to convey a pragmatic approach to the problem. Guidelines have multiplied over the last decade, and their utility has become increasingly conflicted as the reader interprets all suggestions or recommendations as something that must be followed. The nuances of grade of recommendation vs level of evidence are often ignored, and the difference between a "we suggest" vs a "we recommend" is overlooked. There is a general unease among clinicians that failure to follow the guidelines translates to poor medical practice and legal culpability. We attempt to overcome these limitations by highlighting ambiguity when it occurs and refraining from dogmatic recommendations in the absence of robust evidence. Readers and practitioners may find the lack of specific recommendations unsatisfactory, but we believe that true ambiguity is better than inaccurate certainty. We have attempted to comply with the guidelines on how to create guidelines. And to overcome the poor compliance with these guidelines. Some observers have expressed concern that DVT prophylaxis guidelines may cause more harm than good. We have placed greater emphasis on large randomized controlled trials (RCTs) with clinical end point and de-emphasized RCTs with surrogate end points and also de-emphasized hypothesis generating studies (observational studies, small RCTs, and meta-analysis of these studies). We have de-emphasized RCTs in non-intensive care unit populations like postoperative patients or those with cancer and stroke. We have also considered resource limitation settings and have avoided recommending costly and poorly proven therapeutic options.
Jagiasi BG, Chhallani AA, Dixit SB, Kumar R, Pandit RA, Govil D, . Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit. Indian J Crit Care Med 2022;26(S2):S51-S65.
深静脉血栓形成(DVT)是危重症可预防的并发症,本指南旨在传达针对该问题的实用方法。在过去十年中,指南数量激增,而随着读者将所有建议或推荐都视为必须遵循的内容,其效用也变得越来越矛盾。推荐等级与证据水平的细微差别常常被忽视,“我们建议”和“我们推荐”之间的区别也被忽略。临床医生普遍感到不安的是,不遵循指南会被视为医疗行为不当和法律罪责。我们试图通过在出现模糊性时加以强调,并在缺乏有力证据时避免教条式的建议来克服这些局限性。读者和从业者可能会觉得缺乏具体建议不尽人意,但我们认为真正的模糊性总比不准确的确定性要好。我们已尝试遵循关于如何制定指南的指南,并克服对这些指南的依从性差的问题。一些观察家担心DVT预防指南可能弊大于利。我们更加重视有临床终点的大型随机对照试验(RCT),而淡化有替代终点的RCT以及假设生成研究(观察性研究、小型RCT以及这些研究的荟萃分析)。我们淡化了在非重症监护病房人群(如术后患者或癌症及中风患者)中的RCT。我们还考虑了资源受限的情况,避免推荐昂贵且未经充分证实的治疗方案。
Jagiasi BG, Chhallani AA, Dixit SB, Kumar R, Pandit RA, Govil D, 。印度重症医学学会关于重症监护病房预防静脉血栓栓塞的共识声明。《印度重症医学杂志》2022;26(S2):S51 - S65。